Project Oncology®

190 Episoder

1. Analyzing Toxicity Trends Post-CAR T-Cell Therapy: Implications for Patient Monitoring

   Publisert: 23.7.2025
2. Sickle Cell Disease Care: Balancing Disease-Modifying and Curative Therapies

   Publisert: 22.7.2025
3. Cardiac Complications in Sickle Cell Disease: Emerging Evidence and Risks

   Publisert: 21.7.2025
4. Debunking CAR T-Cell Myths: The Realities of Patient Selection, Safety, and Access

   Publisert: 23.6.2025
5. Subcutaneous Cancer Immunotherapy at Home: Transforming Trials and Patient Care

   Publisert: 10.6.2025
6. Bringing Cancer Care Home: How Subcutaneous Immunotherapy Can Help Ease the Burden

   Publisert: 5.6.2025
7. Unpacking the Logistics of At-Home Subcutaneous Cancer Immunotherapy Delivery

   Publisert: 5.6.2025
8. Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study

   Publisert: 3.6.2025
9. Trial in Progress: Phase 3 MoonRISe-3 Study

   Publisert: 1.5.2025
10. First Results From Cohort 4 of the SunRISe-1 Trial

    Publisert: 1.5.2025
11. HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)

    Publisert: 15.4.2025
12. Targeting CD123 in AML: The Latest Therapeutic Advancements

    Publisert: 11.4.2025
13. Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies

    Publisert: 7.4.2025
14. Navigating a Positive MCED Test and Negative Diagnostic Workup: Real-World Data

    Publisert: 28.3.2025
15. AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy

    Publisert: 14.3.2025
16. Chemotherapy Strategies for Metastatic PDAC

    Publisert: 13.1.2025
17. Diagnosis and Management of Metastatic PDAC

    Publisert: 13.1.2025
18. Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care

    Publisert: 8.1.2025
19. Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management

    Publisert: 7.1.2025
20. Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data

    Publisert: 7.1.2025